Equity Compensation (Tables)
9 Months Ended
Sep. 30, 2015
Equity Compensation  
Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

   

 

 

   

 

 

   

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

Shares Subject

 

Average

 

Weighted

 

Remaining

 

 

 

to Options

 

Grant Date

 

Average

 

Contractual

 

 

   

Outstanding

   

Fair Value

   

Exercise Price

   

Life (Years)

 

Balance at December 31, 2014

 

4,851,221

 

 

 

 

$

10.57

 

 

 

Granted

 

212,616

 

$

5.53

 

 

10.95

 

 

 

Exercised

 

(239,726)

 

 

 

 

 

4.82

 

 

 

Expired

 

(13,651)

 

 

 

 

 

12.33

 

 

 

Forfeited

 

(109,170)

 

 

 

 

 

15.37

 

 

 

Balance at September 30, 2015

 

4,701,290

 

 

 

 

 

10.76

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options at September 30, 2015

 

3,001,261

 

 

 

 

 

8.28

 

5.2

 

Vested and expected to vest at  September 30, 2015

 

4,570,238

 

 

 

 

 

10.63

 

6.3

 

 

Summary of stock options outstanding and exercisable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

    

 

 

    

 

    

Weighted-

    

 

    

Weighted-

 

 

 

 

 

 

Weighted

 

 

 

Average

 

 

 

Average

 

 

 

 

 

 

Average

 

Number of

 

Remaining

 

Number of

 

Remaining

 

 

 

 

 

 

Exercise

 

Underlying

 

Contractual

 

Underlying

 

Contractual

 

Range of Exercise Prices

    

Price

    

Shares

    

Life (in years)

    

Shares

    

Life (in years)

  

$

1.71

-

2.66

 

 

2.47

 

211,587

 

1.1

 

211,587

 

1.1

 

$

3.38

-

6.14

 

 

5.64

 

1,437,561

 

4.6

 

1,428,774

 

4.6

 

$

6.34

-

9.94

 

 

8.34

 

1,013,900

 

6.5

 

769,963

 

6.0

 

$

11.28

-

16.97

 

 

13.71

 

1,272,685

 

8.3

 

279,527

 

6.3

 

$

17.66

-

22.92

 

 

20.99

 

765,557

 

8.2

 

311,410

 

7.8

 

 

 

 

 

 

 

 

 

4,701,290

 

 

 

3,001,261

 

 

 

 

Summary of aggregate intrinsic-value of options exercised, exercisable, and vested and expected to vest

The following table summarizes the aggregate intrinsic-value of options exercised, exercisable and vested and expected to vest (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

For the Nine Months Ended

 

 

 

and as of September 30,

 

 

    

2014

    

2015

 

Options Exercised

 

$

17,856

 

$

1,327

 

Options Exercisable

 

 

19,883

 

 

5,333

 

Options Vested and Expected to Vest

 

 

23,644

 

 

5,389

 

 

Summary of restricted stock unit activity

 

 

 

 

 

 

 

 

 

Number of

 

Weighted Average

 

 

    

Shares

    

Grant Date Fair Value

 

Non-vested balance at December 31, 2014

 

 —

 

 

 

 

Awarded

 

388,000

 

$

8.30

 

Vested

 

 —

 

 

 

 

Forfeited

 

 —

 

 

 

 

Non-vested balance at September 30, 2015

 

388,000

 

 

 

 

 

Schedule of assumptions used to estimate fair value of option awards

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2014

    

 

2015

    

 

2014

    

 

2015

 

 

Expected volatility

 

57

-

58

%  

 

 

 

53

%  

 

56

-

60

%  

 

53

-

55

%  

 

Expected dividends

 

 

 

 —

%  

 

 

 

 —

%  

 

 

 

 —

%  

 

 

 

 —

%  

 

Expected terms (in years)

 

 

 

6.1

 

 

5.3

-

6.1

 

 

3.8

-

6.1

 

 

5.3

-

6.1

 

 

Risk-free rate

 

1.8

-

1.9

%  

 

1.5

-

1.8

%  

 

1.1

-

2.0

%  

 

1.3

-

1.8

%  

 

 

Schedule of total stock-based compensation expense classified in statements of operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

    

2014

    

2015

    

2014

    

2015

 

Cost of revenue

 

$

29

 

$

40

 

$

77

 

$

126

 

Research and development

 

 

562

 

 

706

 

 

1,682

 

 

2,145

 

Sales and marketing

 

 

296

 

 

457

 

 

810

 

 

1,298

 

General and administrative

 

 

452

 

 

605

 

 

1,425

 

 

1,767

 

Total stock-based compensation expense

 

$

1,339

 

$

1,808

 

$

3,994

 

$

5,336